As if there weren't enough streaming platforms to choose from, Paramount+ and Showtime are giving customers another option to consider.
The two entities are merging to form Paramount+ with Showtime, a move that will integrate all of the premium cable network's content into a premium streaming tier on Paramount+. With more households cutting their cable cords, integrating content onto a streaming platform will allow more eyes on Showtime's content, Bob Bakish, Paramount CEO, said in a statement.
"Now, with SHOWTIME's content integrated into our flagship streaming service, and select Paramount+ originals joining the linear offering, Paramount+ will become the definitive multi-platform brand in the streaming space -– and the first of its kind to integrate streaming and linear content in this way," he said.
Chris McCarthy, president and CEO of Paramount Media Networks and Showtime, said that investments will be diverted away from unsuccessful projects to clear a path for the cable network's hit shows to reach a global audience.
"As a part of Paramount+, we can put more resources into building out the lanes that have made the SHOWTIME brand more famous, as well as turning our hit shows into global hit franchises," he said.
More information on the merger is expected to be revealed in the coming weeks. Paramount Global, parent company of Paramount+, is set to report earnings on February 16.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
